Analysis of chronic heart failure of coronary heart disease and ventricular arrhythmia
10.3760/cma.j.issn.1008-6706.2015.05.020
- VernacularTitle:冠心病慢性心力衰竭患者并发室性心律失常特征分析
- Author:
Kelu SUN
;
Aixia LIAN
;
Min XU
;
Jingwu WANG
;
Binbin LI
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Heart failure,congestive;
Arrhy thmia
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(5):699-701
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the treatment and pathogenetic condition of chronic heart failure of coro -nary heart disease(CHD) and ventricular arrhythmia (VA).Methods 100 patients with chronic heart failure were collected to observe the treatment of chronic heart failure and pathogenetic condition of VA .Results 44 cases occured VA and 56 cases without VA in 100 patients.NT-proBNP(3 110.00 ±522.00)pg/mL of VA group was sig-nificantly higher than that (2 200.00 ±486.00)pg/mL of non-VA group(t=8.996,P<0.05).LVEF(0.25 ± 0.08) of VA group was lower than that of non -VA group(0.41 ±0.98) (t=11.625,P<0.05).The occurrence (100.00%) of premature ventricular contraction ( PVC) of ≥70mm group in left ventricular internal diameter (LVID) was higher than that of 60 -69mm group (60.87%),50 -59mm group (37.04%),40 -49mm group
(15.38%) with statistically significant(χ2 =5.853,12.532,27.375,all P<0.05).The amount(44.20 ±12.90)mg of use βreceptor blockers of amiodarone group was significantly lower than that of non -amiodarone group(44.20 ± 12.90)mg (t=5.284,P<0.05).Conclusion NT-proBNP of CHEF of CHD and VA patients will improve and amiodarone can reduce the amount of use anti -heart failure drug .
